HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gastric adenocarcinoma presenting with intestinal pseudoobstruction, successfully treated with octreotide.

Abstract
Intestinal pseudoobstruction has been reported as a paraneoplastic manifestation of several cancers, including those of gastrointestinal tract. Octreotide, a somatostatin analogue, has been used successfully in the treatment of idiopathic and scleroderma-associated intestinal pseudoobstruction. We report a 65-year-old man with carcinoma stomach presenting with intestinal pseudoobstruction, which responded to octreotide.
AuthorsSanjay Sharma, Uday C Ghoshal, Ganesh Bhat, Gourdas Choudhuri
JournalIndian journal of medical sciences (Indian J Med Sci) Vol. 60 Issue 11 Pg. 467-70 (Nov 2006) ISSN: 0019-5359 [Print] India
PMID17090868 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents, Hormonal
  • Gastrointestinal Agents
  • Octreotide
Topics
  • Adenocarcinoma (complications, diagnostic imaging, drug therapy)
  • Aged
  • Antineoplastic Agents, Hormonal (therapeutic use)
  • Gastrointestinal Agents (therapeutic use)
  • Humans
  • Intestinal Pseudo-Obstruction (etiology)
  • Male
  • Octreotide (therapeutic use)
  • Radiography
  • Stomach Neoplasms (complications, diagnostic imaging, drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: